Rybelsus, a groundbreaking medication for type 2 diabetes, operates through its unique mechanism of action. By mimicking the incretin hormone GLP-1, it effectively stimulates insulin secretion in response to food intake. Additionally, this medication decreases glucagon release, which plays a vital role in regulating blood glucose levels. Patients often experience…